Thursday, June 23rd, 2016 - WiseGuyReports

WiseGuyReports.com adds“Congestive Heart Failure (CHF) Treatment Devices 2016 Market to Grow at CAGR 5.5% and Reach $14,823.3 million to 2020”reports to its database.

COMPLETE REPORT DETAILS @ https://www.wiseguyreports.com/reports/world-congestive-heart-failure-chf-treatment-forecasts-2015-2022

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).

The world CHF treatment devices market was evaluated at $10,127.2 million in 2015, and is estimated to reach $14,823.3 million by 2022, with a CAGR of 5.5% over the forecast period. This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.

 For more information or any query mail at [email protected]

The report segments the world CHF treatment devices market based on product type, namely, pacemakers, cardiac resynchronization therapy (CRT) devices, implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs). Pacemaker is further segmented into dual-chamber pacemakers and single-chamber pacemakers. CRT devices is segmented into two major types, namely, CRT-P and CRT-D. ICDs is further segmented into transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). VADs is also segmented into left ventricular assist device (LVAD), right ventricular assist device (RVAD), and biventricular assist device (BIVAD). ICDs was the highest revenue-generating segment in 2015, owing to the stressful hyperactive lifestyle, unhealthy food habits, and growing number of aging population. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions.

The key players in this market adopted product development and product launch as their key strategies to keep pace with the changing demands of consumers. Furthermore, companies launched cost-effective and technologically efficient products to strengthen their market position. The report provides a comprehensive analysis of the key players operating in the world CHF treatment devices market, such as Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc.

 REQUEST FOR SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/world-congestive-heart-failure-chf-treatment-forecasts-2015-2022

Key Benefits

The study provides an in-depth analysis of the world CHF treatment devices market with current trends and future estimations to elucidate the imminent investment pockets in the market. 
The report provides a quantitative analysis from 2015 to 2022 that would enable the stakeholders to capitalize on prevailing market opportunities. 
Extensive analysis of the world CHF treatment devices market, by product, helps in understanding the various types of devices used for the treatment of CHF and other related cardiac conditions. 
Competitive intelligence highlights the business practices followed by leading market players across various geographic regions. 
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation. 

CONGESTIVE HEART FAILURE (CHF) TREATMENT DEVICES MARKET KEY SEGMENTS:

Congestive Heart Failure (CHF) Treatment Devices Market, By Product 
Pacemakers, By Type 
Implantable Pacemakers 
External Pacemakers 
Cardiac Resynchronization Therapy (CRT), By Type 
Cardiac Resynchronization Therapy-Pacemakers (CRT-P) 
Cardiac Resynchronization Therapy-Defibrillators (CRT-D) 
Implantable Cardioverter Defibrillators (ICDs), By Type 
Transvenous Implantable Cardioverter Defibrillator (T-ICDs) 
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) 
Ventricular Assist Devices (VADs), By Type 
Left Ventricular Assist Device (LVAD) 
Right Ventricular Assist Device (RVAD) 
Biventricular Assist Device (BIVAD) 

By Geography 

North America 
U.S. 
Canada 
Mexico 
Europe 
Germany 
U.K. 
France 
Rest of Europe 
Asia-Pacific 
Japan 
China 
India 
Rest of Asia-Pacific 
LAMEA 
Latin America 
Middle East 
Africa

 GET EXCLUSIVE DISCOUNT ON THIS REPORT @ https://www.wiseguyreports.com/check-discount/world-congestive-heart-failure-chf-treatment-forecasts-2015-2022

For more information or any query mail at [email protected]

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

Congestive Heart Failure (CHF) Treatment Devices,Congestive Heart Failure (CHF) Treatment Devices Industry,Congestive Heart Failure (CHF) Treatment Devices Market,Congestive Heart Failure (CHF) Treatment Devices Market Trend,Congestive Heart Failure (CHF)

Categories

Newsrooms

Sharing

More Formats